Literature DB >> 6301364

Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.

F N Judson, J M Ehret, C J Root.   

Abstract

Uncomplicated gonorrhea of 122 mucosal sites in 51 women was successfully treated with either a single intramuscular dose of 250 mg of ceftriaxone (23 patients) or two intramuscular doses of 4.8 X 10(6) U of aqueous procaine penicillin G (28 patients). Women treated with ceftriaxone had 22 cervical, 12 urethral, 10 anal canal, and 5 pharyngeal infections. All 122 pretreatment isolates were inhibited by 0.0125 microgram or less of ceftriaxone per ml. The minimal concentration needed to inhibit 90% of isolates was 0.006 microgram/ml for ceftriaxone and 0.2 microgram/ml for penicillin G. Ceftriaxone was very well tolerated and caused no toxicity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301364      PMCID: PMC186025          DOI: 10.1128/AAC.23.2.218

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.

Authors:  W S Ng; P Y Chau; K Arnold
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

2.  Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.

Authors:  I H Patel; R E Weinfeld; J Konikoff; M Parsonnet
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

3.  Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

Authors:  H C Neu; N J Meropol; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

4.  Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits.

Authors:  R C Johnson; R F Bey; S J Wolgamot
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

5.  In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.

Authors:  K Shannon; A King; C Warren; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

6.  Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.

Authors:  H H Handsfield; V L Murphy; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

7.  Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.

Authors:  M J Hall; D Westmacott; P Wong-Kai-In
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

  7 in total
  10 in total

1.  Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.

Authors:  C A Dixon; J B Bittiner; M Shahidullah; R C Slack; M Z Sulaiman
Journal:  Genitourin Med       Date:  1986-04

2.  The potential uses of ceftriaxone.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

Review 3.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 5.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 6.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

7.  Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

8.  Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.

Authors:  K Panikabutra; C Ariyarit; A Chitwarakorn; C Saensanoh; C Wongba
Journal:  Genitourin Med       Date:  1985-04

9.  In vitro activity of selected antimicrobial agents against penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.

Authors:  D J Waghorn; B S Azadian; C Talboys
Journal:  Genitourin Med       Date:  1986-12

10.  Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis.

Authors:  Jiaru Yang; Subhash Dhital; Thomas Naderer
Journal:  J Clin Med       Date:  2019-12-11       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.